Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Mar 15;37(2):BSR20160611.
doi: 10.1042/BSR20160611. Print 2017 Apr 30.

Novel insights into DNA methylation and its critical implications in diabetic vascular complications

Affiliations
Review

Novel insights into DNA methylation and its critical implications in diabetic vascular complications

Jia Zheng et al. Biosci Rep. .

Abstract

Recent epidemiological and clinical studies have shown that type 2 diabetic patients can develop diabetic vascular complications even after intensive glycaemic control. It has been suggested that this phenomenon could be explained by the hypothesis of 'metabolic memory'. The underlying mechanisms between these enduring effects and the prior hyperglycaemic state are still not well understood. Preliminary studies demonstrate that hyperglycaemia can regulate gene expression by epigenetic modifications, such as DNA methylation, which can persistently exist even after glucose normalization. Increasing evidence shows that epigenetic mechanisms may play a substantial role in the pathophysiology of diabetes and its associated vascular complications, including atherosclerosis, diabetic cardiomyopathy (DCM), nephropathy and retinopathy. In this review, we will examine the growing role of DNA methylation in diabetes and its vascular complications, thus it can provide critical implications for the early prevention of diabetes and its vascular complications.

Keywords: Atherosclerosis; DNA methylation; Diabetic cardiomyopathy; Diabetic nephropathy; Diabetic retinopathy; Epigenetics.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there are no competing interests associated with the manuscript.

Figures

Figure 1
Figure 1. Schematic diagram shows the role of epigenetic mechanisms in metabolic memory and diabetic vascular complications
Metabolic memory is the phenomenon of diabetic vascular stresses persisting after glucose normalization in diabetic patients because of early a hyperglycaemic environment. Increasing studies show that epigenetics may be the underlying mechanisms, which can explain metabolic memory. Epigenetic mechanisms including DNA methylation, histone methylation, histone acetylation, are regulated via the action of corresponding DNMTs, HMTs and HATs. In addition, miRNAs can also play a significant role in the process. Together they activate multiple signal transduction pathways and regulated related gene expression, involving blood vessels, heart, kidney and eyes. Then, it can increase the susceptibility of macrovascular complications such as atherosclerosis, DCM and microvascular complications such as nephropathy and retinopathy. ECs, endothelial cells; VSMCs, vascular smooth muscle cells.
Figure 2
Figure 2. Molecular mechanisms of DNA methylation
DNA methylation is exerted by DNMTs at the 5′-position of cytosine residues in CpG dinucleotides (the p denotes the intervening phosphate group) by transferring methyl groups from SAM, thus 5-methylcytosine is formed. DNA methylation of promoter CpG islands generally can regulate gene expression.

References

    1. International Diabetes Federation (2015) IDF Diabetes Atlas, 7th edn, IDF, Brussels, Belgium
    1. Pirola L., Balcerczyk A., Okabe J. and El-Osta A. (2010) Epigenetic phenomena linked to diabetic complications. Nat. Rev. Endocrinol. 6, 665–675 - PubMed
    1. Ceriello A., Testa R. and Genovese S. (2016) Clinical implications of oxidative stress and potential role of natural antioxidants in diabetic vascular complications. Nutr. Metab. Cardiovasc. Dis. 26, 285–292 - PubMed
    1. Chawla A., Chawla R. and Jaggi S. (2016) Microvasular and macrovascular complications in diabetes mellitus: distinct or continuum? Indian J. Endocrinol. Metab. 20, 546–551 - PMC - PubMed
    1. Cooper M.E. and Johnston C.I. (2000) Optimizing treatment of hypertension in patients with diabetes. JAMA 283, 3177–3179 - PubMed

Publication types

MeSH terms